8-iso-16-cyclohexyl-tetranor Prostaglandin E2 (8-iso-16-cyclohexyl-tetranor PGE2)
98%
- Product Code: 107412
CAS:
53319-30-5
| Molecular Weight: | 378.5 g./mol | Molecular Formula: | C₂₂H₃₄O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
This compound is primarily used in research settings to study the biological effects of prostaglandins, particularly in understanding inflammation and cellular signaling pathways. It serves as an analog to naturally occurring prostaglandins, allowing scientists to investigate how these molecules influence processes like smooth muscle contraction, blood flow regulation, and immune responses. Its modified structure provides insights into the structure-activity relationship of prostaglandins, aiding in the development of therapeutic agents targeting prostaglandin-related disorders. Additionally, it is utilized in pharmacological studies to explore its potential in treating conditions such as cardiovascular diseases, glaucoma, and reproductive health issues.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £1,538.25 |
+
-
|
8-iso-16-cyclohexyl-tetranor Prostaglandin E2 (8-iso-16-cyclohexyl-tetranor PGE2)
This compound is primarily used in research settings to study the biological effects of prostaglandins, particularly in understanding inflammation and cellular signaling pathways. It serves as an analog to naturally occurring prostaglandins, allowing scientists to investigate how these molecules influence processes like smooth muscle contraction, blood flow regulation, and immune responses. Its modified structure provides insights into the structure-activity relationship of prostaglandins, aiding in the development of therapeutic agents targeting prostaglandin-related disorders. Additionally, it is utilized in pharmacological studies to explore its potential in treating conditions such as cardiovascular diseases, glaucoma, and reproductive health issues.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :